MTNB icon

Matinas BioPharma

64 hedge funds and large institutions have $67.4M invested in Matinas BioPharma in 2019 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 8 closing their positions.

Holders
64
Holders Change
+26
Holders Change %
+68.42%
% of All Funds
1.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
11
Reduced
5
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
FC
51
Fore Capital
New York
$23K 10,000
Franklin Resources
52
Franklin Resources
California
$23K 10,000 +10,000 New
BFM
53
Boothbay Fund Management
New York
$23K 10,000 +10,000 New
Citigroup
54
Citigroup
New York
$23K 10,000 +10,000 New
FAIM
55
Financial Advocates Investment Management
Washington
$23K 10,000 +10,000 New
AG
56
Advisor Group
Arizona
$9K 4,000
UBS Group
57
UBS Group
Switzerland
$8K 3,617 +3,617 New
HFM
58
Hartford Financial Management
Connecticut
$6K 2,500
CAL
59
Capital Analysts LLC
Pennsylvania
$3K 1,264 +1,264 New
EWM
60
Endurance Wealth Management
Rhode Island
$2K 1,250 +1,250 New
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$57 25 -2 -7%
WCA
62
Windsor Creek Advisors
Vermont
$33 14,679 +14,679 New
GPCM
63
Granite Point Capital Management
Massachusetts
-1,500,000 Closed
TI
64
Telemetry Investments
New York
-431,544 Closed
LTFS
65
Ladenburg Thalmann Financial Services
Florida
-25,000 Closed
RJA
66
Raymond James & Associates
Florida
-17,000 Closed
Two Sigma Investments
67
Two Sigma Investments
New York
-11,270 Closed
GIA
68
Gladstone Institutional Advisory
Florida
-10,000 Closed
Fidelity Investments
69
Fidelity Investments
Massachusetts
-1,221 Closed
Barclays
70
Barclays
United Kingdom
-20 Closed
IA
71
IFP Advisors
Florida
VFA
72
Valeo Financial Advisors
Indiana
$0 200
CFGS
73
Concourse Financial Group Securities
Alabama
TWA
74
TCI Wealth Advisors
Arizona
$0 100 +100 New